Binish Chudgar – Vice Chairman & MD, Intas, India

In this exclusive interview, Binish Chudgar, vice-chairman and managing director of Intas, the largest privately-owned Indian pharmaceutical company with sales of over USD 1.7 billion during the last financial year, provides insights into the company's growth model and M&A approach, as well as his objectives with regards to a large-scale acquisition in the US. He also gives us an overview of the company’s biosimilar strategy, his assessment of the compliance issues affecting the Indian industry and the price erosion shaping the US generics market.  
In terms of geographic expansion, we truly look at building a balanced footprint, where the varying performances of our different markets compensate each other
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report